Rapid development of COVID-19 vaccines has helped mitigating SARS-CoV-2 spread, but
more equitable allocation of vaccines is necessary to limit the global impact of the COVID-19 …

The COVID-19 pandemic represents a milestone in vaccine research and development in a
global context. A worldwide effort, as never seen before, involved scientists from all over the …

Several COVID-19 vaccines have now been deployed to tackle the SARS-CoV-2 pandemic,
most of them based on messenger RNA or adenovirus vectors. The duration of protection …

Human respiratory syncytial virus (HRSV), human metapneumovirus (HMPV), and human
parainfluenza viruses (HPIVs) are leading causes of respiratory disease in young children …

Under the pressure of the COVID‐19 pandemic, vaccines were developed and rolled out
into mass vaccination campaigns at incredible speed. What normally takes a decade was …

The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to dramatic economic and health …

We developed an intranasal vaccine against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) using the replication-incompetent human parainfluenza virus type 2 …

Rapid development of coronavirus disease 2019 (COVID-19) vaccines and expedited
authorization for use and approval has been proven beneficial to mitigate severe acute …

Emergence of SARS-CoV-2 variants of concern (VOC), including the highly transmissible
delta strain, has posed challenges to current COVID-19 vaccines that principally target the …

The coronavirus disease 2019 (Covid-19) pandemic has been challenging the entire world
since early 2020. Due to the fact that there is no universally available treatment method …